• Andromeda Robotics

  Participated · Series A · Sep 2025

  Andromeda builds Abi, a next-generation humanoid companion robot and has launched its latest model. The company will begin first deployments at a mecwacare aged care home this month. Andromeda plans to focus initially on aged care as it expands into the US while continuing to scale operations and teams in Australia. The raise is intended to accelerate US expansion, fast-track the Australian waitlist, and support hiring across engineering and customer success. In the US the company is prioritising recruitment of creative and animation robotics specialists. Andromeda emphasised the funding will help bring Abi’s companionship to more customers and partners across aged care and other sectors. Andromeda Robotics builds Abi, a humanoid companion robot designed to provide companionship and support to older adults in aged care facilities and children in hospitals. Abi was developed with input from Disney and Pixar animators and uses AI and machine learning to customize interactions, respond to questions, express emotions, recognize faces, and remember past interactions. The robot assists with daily tasks and offers social and cognitive support to enhance users' quality of life and independence. Abi's personality will be customizable through an upcoming app, with options such as a 'sarcastic coach' highlighted as popular. Andromeda has progressed with limited funding and recently raised a $3 million seed round to scale Abi across Australia. The company plans to use the new capital to improve Abi's capabilities, grow the team, and move to larger manufacturing facilities in South Melbourne.

• Proton

  Participated · Seed · Dec 2024

  Proton is developing a small device designed to be inserted just below the skin to continuously monitor potassium levels and pair with a smartphone app for patient alerts. A clinician dashboard is planned so care teams can view potassium trends and fine-tune therapies, potentially reducing in-clinic potassium testing, time, and costs. The company targets patients with chronic kidney disease and those at risk of heart failure, where potassium imbalances can be life‑threatening. Clinical trials are underway for the product, which Proton says is due to launch in 2025. The founders are CEO Sahan Ranamukhaarachchi (based in Vancouver) and CSO Victor Cadarso (based in Melbourne); the company has a commercial HQ in Canada and an R&D subsidiary in Melbourne, Australia. Proton positions its approach against other emerging potassium-monitoring firms and claims greater scalability, usability, and clinical impact.

• MediQuo

  Participated · Equity · Apr 2023

  MediQuo provides a secure platform for medical professionals to attend patients by chat, call or videoconference, with professional tools to facilitate telematic communication. The company reports 1.2 million registered users and handles about 1.5 million consultations annually. It has commercial agreements with Asisa, Centros de Atención Primaria Capsbe (CatSalut), GSK, Novo Nordisk, AIG and Inmedical. MediQuo expected to reach break even at the close of 2022 and projects €20 million in sales by 2027. The recently raised funds are intended to consolidate growth in Spain and accelerate internationalization across Latin America. The product is positioned in the HealthTech/telemedicine segment and targets both patient-facing consultations and partnerships with healthcare organisations. MediQuo offers a WhatsApp‑inspired telemedicine app and web platform that lets validated health professionals consult with patients by chat, voice, or video. The company launched in November 2017 and focuses its growth on Spain and Latin America, serving both consumers and B2B2C clients such as insurers, hospitals, pharmaceutical companies and employers. MediQuo reports more than 800,000 registered users, over 1 million consultations in one year, a 4.6/5 rating from over 10,000 reviews, and has 1,500 validated professionals using MediQuo PRO. In 2020 the company launched mediQuo PRO, a SaaS tool for professionals available as app and web, and says sales grew 700% that year. Current plans with the new funding include commercial expansion, consolidating product vision, developing a high‑value app and web version for professionals, and signing further B2B2C agreements to deepen market position. mediQuo is a Barcelona, Spain-based eHealth app that provides a platform to manage medical consultations. By the end of 2019 the app had recorded 940,000 medical consultations and 570,000 mobile downloads. The company closed a €2m funding round from investors in the health sector, various venture capital investors and family offices. It intends to use the funds to continue expanding operations and its business reach. mediQuo will soon launch mediQuo PRO to allow doctors and health professionals to manage consultations online for both their own patients and the app's users. With mediQuo PRO the company aims to reach 14,000 health professionals and to manage 1.5 million patient consultations within the next 15 months. The business was founded by Albert Castells, José López and Guillem Serra and is also led by Bruno Cuevas. Mediquo offers a medical chat application that lets patients contact licensed doctors across specialties with unlimited messages and typical responses in under two minutes. The app was founded by Guillem Serra, José López and Albert Castells and aims to provide medical attention from the smartphone around the clock. It operates in Spain, Peru, Argentina and Chile, has begun offering services in the United States, and has not ruled out expansion to Asia (China). Since launch in Spain the app has been downloaded by more than 30,000 users and logged over 145,000 medical consultations. The company’s stated goal is to be a "medical friend" in users' pockets, delivering rapid access to care. Mediquo recently closed a venture capital financing to support its growth and international rollout. MediQuo operates a medical chat application that lets users contact licensed doctors across specialties directly from their phones. After downloading the app, patients can message doctors unlimitedly and typically receive responses in under two minutes. The company was founded by Guillem Serra, José López and Albert Castells; Guillem Serra is CEO and co-founder. MediQuo's stated mission is to bring medicine to everyone, provide medical orientation or second opinions, and recover the traditional proximity between patients and physicians. The startup closed a financing round of €3 million to support its growth and service expansion. The company is based in Barcelona and the funding was reported by El Referente.

• LUMOS

  Participated · Seed · Sep 2022

  LUMOS, founded in 2020 and based in Sydney, pairs gig-economy riders with IoT-enabled digital billboard backpacks (Smart Bags) to deliver physical ads and enable device tracking for digital retargeting. Its proprietary LUMOS data engine enriches out-of-home ads with advanced audience analytics and digital retargeting capabilities. The company says it currently works with 20+ domestic and international brands and agencies. In August 2022 LUMOS raised an oversubscribed $800,000 pre-seed round. The startup will use the funds to scale its footprint across Australia, further develop advanced data-driven ad reporting, and roll out additional IoT-enabled ad solutions across multiple cities.

• Zywa (YC W22)

  Participated · Seed · Aug 2022

  Zywa provides a social banking app and prepaid card aimed at Gen Z (ages 11–25) to receive money, manage funds, and make payments. The app includes parental controls so parents can send money and monitor their children’s spending and saving habits. Zywa plans product features that add a social layer for sharing purchases, community value-adds such as an in-app internships platform, and gamified finance with rewards called Zems and Zyons. The company intends to tokenize those rewards once it reaches a set volume of users (100,000+), enabling peer-to-peer transfers and closed-loop merchant settlements. Zywa earns from card interchange revenue and merchant or brand partnerships. It plans to focus on product, growth, and strategic partnerships and to expand beyond the UAE into Egypt and Saudi Arabia.

No current team members are available.